The Yuzu Story

Advancing Pain Relief Through Medical Cannabis Research

Seven years ago a group of physicians and scientists started out to make a difference in medicinal cannabis with an emphasis on medicinal.

By June of 2018, we presented at the American Society of Clinical Oncology meeting our first results using a combination of THC/CBD to reduce the amount of opiates required for long-standing chronic pain.

We demonstrated a 75% reduction in opiate consumption and were featured on multiple news channels and our results were published. (1) Unfortunately, it became clear that we were outliers in this industry and sold our interests in the THC space as recreational use was the driving force there and this wasn’t compatible with our goals.

We clearly understand the potential of cannabinoids to affect overall wellness and think the CBD arena is more in line with our goals as a company: impacting both human and animal wellness.

WHY CHOOSE OUR YUZU

PHYSCIAN-FOUNDED COMPANY

As a physician-founded company, we believe that it is important to be medically accurate regarding our products. Although there is a wealth of anecdotal information regarding the effectiveness of broad-spectrum CBD and cannabinoids, in general, acting as anti-inflammatories, there are few, if any randomized trials (gold standard) completed at this time. At YUZU CBD plus we have incorporated supplements supporting joint health (Glucosamine, Chondroitin, and MSM) as well as an essential element from the YUZU citrus which has a documented anti-inflammatory effect in an effort to create a synergism towards the endpoint of a feeling better.

HIGH QUALITY PREMIUM CBD

Our broad-spectrum CBD products including salves, lotions, tinctures, suppositories, and edibles have additional components included in their formulation with the intent to improve the outcomes associated with their use. We have worked for two years with chemists and a world-renown chef, Jean-Marie Auboine, to bring products to market that we are proud of and can stand behind.

American Society of Clinical Oncology

We presented at the American Society of Clinical Oncology meeting our first results using a combination of THC/CBD to reduce the amount of opiates required for long-standing chronic pain. We demonstrated a 75% reduction in opiate consumption and were featured on multiple news channels and our results were published.

Doctors, Chemists, and a Chocolatier

We have worked for hard with chemists and a world-renown chef, Jean-Marie Auboine, to bring products to market that we are proud of and can stand behind.